MET Research, Inc. – FDA 483, Jun 8, 2026

An FDA inspection of Charles River Laboratories in Mattawan, MI, a nonclinical laboratory, identified one observation. The study director failed to ensure the proper archiving of all raw data, documentation, protocols, specimens, and final reports for a specific study. Additionally, the study director did not document an exception from regulations in the final report's compliance statement.